Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Interest Expenses (2021 - 2026)

HeartSciences' Interest Expenses history spans 6 years, with the latest figure at $61509.0 for Q1 2026.

  • For Q1 2026, Interest Expenses fell 65.73% year-over-year to $61509.0; the TTM value through Jan 2026 reached $705583.0, up 107.2%, while the annual FY2025 figure was $500453.0, 41.34% up from the prior year.
  • Interest Expenses reached $61509.0 in Q1 2026 per HSCS's latest filing, down from $279534.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $279534.0 in Q4 2025 to a low of $7.0 in Q1 2023.
  • Average Interest Expenses over 5 years is $106220.0, with a median of $117598.0 recorded in 2024.
  • Peak YoY movement for Interest Expenses: crashed 99.99% in 2023, then surged 1691971.43% in 2024.
  • A 5-year view of Interest Expenses shows it stood at $32805.0 in 2022, then soared by 443.94% to $178438.0 in 2023, then plummeted by 34.1% to $117598.0 in 2024, then skyrocketed by 137.7% to $279534.0 in 2025, then tumbled by 78.0% to $61509.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Interest Expenses are $61509.0 (Q1 2026), $279534.0 (Q4 2025), and $183688.0 (Q3 2025).